Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Tylenol recalls, plant improvements spur shortages  Join our daily free Newsletter

MENAFN - - 11/5/2012 11:43:52 AM

Digg This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story.aspx%3fstoryid%3d5a37f0dc-32f2-42dd-b240-8941012abd2f%26src%3dmain Share This Article: http%3a%2f%2fwww.menafn.com%2fmenafn%2fqn_news_story.aspx%3fstoryid%3d5a37f0dc-32f2-42dd-b240-8941012abd2f%26src%3dmain Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!


Tylenol recalls, plant improvements spur shortages

Nov 05, 2012 (Menafn - The Pittsburgh Tribune-Review - McClatchy-Tribune Information Services via COMTEX) --Finding regular and extra-strength Tylenol could be a headache for shoppers at some Western Pennsylvania stores.

McNeil Consumer Healthcare, the division of Johnson & Johnson that produces Tylenol, is upgrading manufacturing facilities and that means a shortage of supply in some regions, the company says.

Tylenol and other products are unavailable or in short supply because the company suspended operations at its Fort Washington plant near Philadelphia and is making changes at other operations, spokeswoman Jodie Wertheim said.

"We continue to work to diligently return our brands back to store shelves," she said.

Company officials suspended operations at the Pennsylvania plant in 2010 after more than 20 recalls of McNeil products. The company is working with the Food and Drug Administration to make improvements at the plant, including revamping the quality-control system.

The company said recalls involving regular and extra-strength Tylenol stemmed from "a small number of odor reports, including musty, moldy odor linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA)."

Health risks associated with TBA can include gastrointestinal problems but typically are minimal, according to the FDA. The agency could not provide information on the number of people who reported becoming ill because of the recalled products.

Finding regular and extra-strength Tylenol in stores can be hit or miss. Giant Eagle at Caste Village in Whitehall had none of either last week, and a location on the North Side had four packages of extra strength available.

Giant Eagle spokesman Dick Roberts said the company is "seeing some effects" from a slowed distribution.

"We're working closely with our counterparts at Johnson & Johnson to make as much as possible available," he said.

Walgreens on McKnight Road had plenty of both available. A company spokesman deferred comment to McNeil.

Rite Aid on Banksville Road had a few boxes for sale.

"When the warehouse has it in stock, we make it readily available to customers," said Rite Aid manager Bob Parenti. "There's not much we can do."

He said no customer has had to go without Tylenol because of low supplies at the store.

"As is the case with other retailers, we are receiving reduced shipments on some of the Tylenol products still being produced. We've been in close contact with the manufacturer to minimize the impact on our store inventory," said Eric Harkreader, Rite Aid spokesman.

He said pharmacists often refer customers to Rite Aid brand products containing the same active ingredients.

The region's hospitals report no shortage of Tylenol, according to representatives.

Consumers can visit www.McNeilConsumer.com for updates regarding product availability.

Rachel Weaver is a staff writer for Trib Total Media. She can be reached at 412-320-7948 or rweaver@tribweb.com.

___ (c)2012 The Pittsburgh Tribune-Review (Greensburg, Pa.) Visit The
Pittsburgh Tribune-Review (Greensburg, Pa.) at
www.pittsburghlive.com/x/pittsburghtrib Distributed by MCT Information Services


 






International Provider
May 20, 2013 Burmese President's White House Visit a Reward for Reforms, FIND Government Press Releases
May 20, 2013 NC Attorney General pans Senate plan to restructure SBI, McClatchy-Tribune Information Services -- Unrestricted
May 20, 2013 Sustainable Energy Announces Extension of $1.5M Standby Equity Commitment by Doughty Hanson Technology Ventures, Marketwire
May 20, 2013 Kohler loses patent case, jury calls for firm to pay $9.6 million, McClatchy-Tribune Information Services -- Unrestricted
May 20, 2013 Sustainable Energy Announces Extension of $1.5M Standby Equity Commitment by Doughty Hanson Technology Ventures, Marketwire Canada
May 20, 2013 BRIEF: Rockville Bank Parent Approves Stock Repurchase, McClatchy-Tribune Information Services -- Unrestricted
May 20, 2013 FBR Announces Allen Morton Has Joined Investment Banking Team as Managing Director and Head of Houston Office, GlobeNewswire
May 20, 2013 Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference, CNW Group
May 20, 2013 Patheon Announces Date of Fiscal 2013 Second Quarter Financial Results, CNW Group
May 20, 2013 Memorial Production Partners LP Announces Pricing of a $100 Million Offering of Additional Senior Notes, GlobeNewswire
more...


 
MENAFN






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country
Marketwatch News
UPI News
Comtex News

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help